Related Experiment Videos
The lung in the immunocompromised patient. Infectious complications part 2
1Division of Pneumology, University Hospital Basel, Switzerland. michaelt@mailmed.usyd.edu.au
Respiration; International Review of Thoracic Diseases
|June 12, 1999
Abstract:
Pulmonary infections decisively contribute to morbidity and mortality in immunocompromised patients. Bacterial, mycobacterial and infections with Pneumocystis carinii have been reviewed in an article in the last issue of Respiration. In this review, viral and fungal pulmonary infections are discussed in HIV-positive patients and in patients treated with high-dose chemotherapy, stem cell or solid-organ transplantation.